Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesVardenafil therapy for patients with pulmonary arterial hypertension. A one-year, multicentre, open-label study
Heart, 07/09/09
Jing ZC et al. - Long-term treatment with vardenafil is well tolerated and has sustained beneficial effects on PAH, as measured by patients¡ exercise capacity, WHO functional class, and haemodynamic parameters.
Related Articles
Vardenafil Improves Erectile Function in Men with Erectile Dysfunction and Associated Underlying Conditions, Irrespective of the Use of Concomitant Medications
The Journal of Sexual Medicine, 10/26/09
Relevance Score: 88%
Acceptance of Therapy In Vardenafil-treated patients with Erectile dysfunction (ACTIVE): a noninterventional study in Germany
International Journal of Impotence Research, 11/13/09
Relevance Score: 83%
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
European Journal of Cardio-Thoracic Surgery, 10/01/09
Relevance Score: 83%
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Annals of Internal Medicine, 10/23/09
Relevance Score: 80%
Studies show Viagra, other drugs outperform hormone treatment
Internet Source, 10/21/09
Relevance Score: 80%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
Tadalafil for the treatment of pulmonary arterial hypertension
Expert Opinion in Pharmacotherapy, 12/14/09
Bosentan for chronic thromboembolic pulmonary hypertension
Expert Review of Cardiovascular Therapy , 12/14/09
Abnormal troponin I levels in acute pulmonary embolism without abnormal concentrations of D-dimer at admission
International Journal of Cardiology, 12/14/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Tadalafil for the treatment of pulmonary arterial hypertension
Expert Opinion in Pharmacotherapy, 12/14/09
Bosentan for chronic thromboembolic pulmonary hypertension
Expert Review of Cardiovascular Therapy , 12/14/09
Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children
Pediatric Allergy and Immunology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor